Gene · 2358
Papers3,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of key genes and pathways of knee osteoarthritis based on GEO data mining. | Medicine (Baltimore) | 2025 | 41327695 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis Reveals Key Regulatory Genes and Therapeutic Targets in Ulcerative Colitis Pathogenesis. | Genes (Basel) | 2025 | 41300749 | PubTator, text mining | PubMed |
| FPR2 at the crossroads of inflammation and repair in the eye. | Drug Discov Today | 2025 | 41270886 | PubTator, text mining | PubMed |
| Research Progress of Annexin A1 and Its Derived Peptides in the Diagnosis and Treatment of Circulatory Diseases. | Immun Inflamm Dis | 2025 | 41208642 | PubTator, text mining | PubMed |
| Poly-ubiquitylated transmembrane proteins outcompete other cargo for limited space inside clathrin-coated vesicles. | Cell Rep | 2025 | 41201087 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and therapeutic targets for underactive bladder based on bioinformatics analysis and experimental validation. | PLoS One | 2025 | 41196851 | PubTator, text mining | PubMed |
| Identification and Validation of a Macrophage Phagocytosis-Related Gene Signature for Prognostic Prediction in Colorectal Cancer (CRC). | Curr Issues Mol Biol | 2025 | 41150752 | PubTator, text mining | PubMed |
| Keratinocyte-neutrophil interactions revealed as targetable drivers of sustained inflammation in Sweet syndrome. | J Clin Invest | 2025 | 41090350 | PubTator, text mining | PubMed |
| Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patients. | Int Immunopharmacol | 2025 | 41082839 | PubTator, text mining | PubMed |
| Elevated LL-37/FPR2 Axis and its Regulatory Role for Gingival Fibroblasts in Periodontitis. | Int Dent J | 2025 | 41072077 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Profiling Reveals a Distinct Monocyte MIF/ANXA1 Signature Associated With Poor Responsiveness to ICS. | Allergy Asthma Immunol Res | 2025 | 41044838 | PubTator, text mining | PubMed |
| Prolonged immune activation in post-acute sequelae of SARS-CoV-2: neutrophil dynamics and therapeutic insights. | Exp Mol Med | 2025 | 40987794 | PubTator, text mining | PubMed |
| Colorectal Neoplasia Pathogenesis in Normal Appearing Colonic Mucosa -A Perspective With Focus on Eicosanoid Signaling Pathways. | Cancer Med | 2025 | 40980975 | PubTator, text mining | PubMed |
| Monoclonal Antibody 5F1 Modulates Formyl Peptide Receptor 1 Conformation for Transmembrane Signaling. | FASEB Bioadv | 2025 | 40927406 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma stem cells: the current state of small molecule-based inhibitors. | Cell Death Dis | 2025 | 40890130 | PubTator, text mining | PubMed |
| Molecular components of the FPR2/ALX pathway participate in astrocyte-neuron resolution responses to afford maneb-induced toxicity. | Cell Mol Life Sci | 2025 | 40886225 | PubTator, text mining | PubMed |
| HUMANIN produced by human efferocytic macrophages promotes the resolution of inflammation. | Cell Death Dis | 2025 | 40877234 | PubTator, text mining | PubMed |
| Asymmetric Synthesis and Biological Evaluation of 1,3- and 1,4-Disubstituted Isoquinoline-Containing Lipoxin A4 Analogues. | Chemistry | 2025 | 40873044 | PubTator, text mining | PubMed |
| Reconstitution of T cell-mediated immunity by umbilical cord-derived mesenchymal stem cells in ulcerative colitis. | Clin Transl Med | 2025 | 40842289 | PubTator, text mining | PubMed |
| SAA1/FPR2 signaling between keratinocytes and neutrophils sustains chronic inflammation in Sweet syndrome. | J Clin Invest | 2025 | 40828601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2358/papers?page=5